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Onuf’s nucleus is a small group of neurons located in the ventral horns of the sacral spinal
cord. The motor neurons (MNs) of Onuf’s nucleus innervate striated voluntary muscles
of the pelvic floor and are histologically and biochemically comparable to the other
somatic spinal MNs. However, curiously, these neurons also show some autonomic-like
features as, for instance, they receive a strong peptidergic innervation. The review
provides an overview of the histological, biochemical, metabolic, and gene expression
peculiarities of Onuf’s nucleus. Moreover, it describes the aging-related pathologies as
well as several traumatic and neurodegenerative disorders in which its neurons are
involved: indeed, Onuf’s nucleus is affected in Parkinson’s disease (PD) and Shy-Drager
Syndrome (SDS), whereas it is spared in Amyotrophic Lateral Sclerosis (ALS), Spinal
Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD). We summarize here
the milestone studies that have contributed to clarifying the nature of Onuf’s neurons
and in understanding what makes them either vulnerable or resistant to damage.
Altogether, these works can offer the possibility to develop new therapeutic strategies
for counteracting neurodegeneration.
Keywords: aging, autonomous nervous system, injury, motor neuron diseases, neurodegeneration, somatic motor
neurons, spinal cord
INTRODUCTION
In 1899, for the first time, the Russian neuroanatomist Bronislaw Onuf (Onufrowicz) identified
and described a group of neurons located in the human sacral spinal cord and involved in the
innervation of the pelvic floor: he called this formation ‘‘nucleus X,’’ later renamed after him
‘‘Onuf’s nucleus.’’
Onuf’s nucleus (Figure 1) has been identified in different locations through the species, similar
in the cat, dog, monkey, and man, differently from the rat, Mongolian gerbil, and domestic
pig (as reviewed by Gerrits et al., 1997). The human Onuf’s nucleus is located in the ventral
horn of the upper sacral segment including S2–S3 and rarely also involving S1 (with an overall
length comprised between 4 and 7 mm). In 1981, Schrøder (1981) described three portions of
human Onuf’s nucleus, distinguishable based on their cytoarchitecture: cranial, dorsomedial and
ventrolateral. Later on, Forger and Breedlove only confirmed the presence of the dorsomedial and
ventrolateral cell groups in humans (Forger and Breedlove, 1986), and this subdivision is generally
still used.
Onuf’s nucleus innervates voluntary striated muscles, and its MNs share several morphological
aspects with other somatic MNs. However, its rich peptidergic innervation suggests its autonomic
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FIGURE 1 | Onuf’s nucleus motor neurons (MNs). Localization of Onuf’s
MNs (in black those innervating ischiocavernosus muscle, in the dorsolateral
column) in rat spinal cord, by horseradish-peroxidase retrograde transport, at
low (A) and high magnification (B,C), in a neutral red-stained section.
Dendrites form characteristic dendritic bundles. The dotted line in panel (A)
outlines the gray matter. Scale bars: 100 µm in panels (A,B), 10 µm in
panel (C).
involvement (Kawatani et al., 1986; Pullen et al., 1997). In 1900,
Onuf and colleagues (Onuf, 1900) reported that it innervates
the only ischiocavernosus (and it’s equivalent in females, erector
clitoridis) and bulbospongiosus (or bulbocavernosus) muscles.
However, later on, other authors clarified that Onuf’s nucleus
also controls the sphincter urethrae membranaceous muscle
(external urethral sphincter muscle, EUS), the levator ani
(elevator muscle of the anus), and the sphincter ani externus
(external anal sphincter, EAS; Gerrits et al., 1997; reviewed by
Mannen, 2000; Figure 2). Therefore, through the control of
the pelvic-perineal muscles, it plays a crucial role in erection
and urinary/fecal continence and participates in ejaculation.
Moreover, some authors have also hypothesized a somatotopic
arrangement in the Onuf’s nucleus (both in humans and in
animals), suggesting that MNs of the dorsomedial portion
innervate the EAS, while those of the ventrolateral portion
innervate the EUS (Iwata et al., 1993).
In 1987, Holstege and Tan traced Onuf’s nucleus afferent
fibers, by using HRP and Tritiated L-Leucine labeling: they
demonstrated a direct connection with the brainstem and
hypothalamus (Holstege and Tan, 1987), therefore confirming
the contribution of Onuf’s nucleus to the basic physiologic
functions regulated by these brain regions. Interestingly, since
the ‘‘80s, direct and specific subcortical projections to Onuf’’s
MNs were shown to originate from both diencephalon and
brainstem (Figure 3), including: (i) the ipsilateral paraventricular
hypothalamic nucleus; (ii) the ipsilateral caudal pontine lateral
reticular formation; and (iii) the contralateral caudal nucleus
retroambiguus (NRA; Holstege and Tan, 1987). Indeed, as
demonstrated in rats by transneuronal virus tracing methods,
many neuronal populations of the CNS are involved in
the supraspinal control of micturition, defecation and sexual
functions (Fowler et al., 2008): some spinal projections are
aspecific diffuse (such as the noradrenergic cells of the locus
FIGURE 2 | Muscles innervated by Onuf’s MNs. Onuf’s (ON) MNs are
located in the ventral horns of the upper sacral segment and innervate
sphincters and muscles of the pelvic and perineal regions, such as the
sphincter ani externus, the sphincter urethrae membranaceae, the
bulbospongiosus, the ischiocavernosus (and its equivalent in females, erector
clitoridis), and the levator ani muscles.
coeruleus, the serotoninergic neurons of the medullary raphe
nucleus and the A5 noradrenergic cell group proximal to the
superior olivary complex in the pontine tegmentum; Fowler et al.,
2008; de Groat, 2017), whereas others specifically regulate pelvic
organ function. These latter include the neurons of pelvic organ
stimulating center (POSC), also known as Barrington’s nucleus
or pontine micturition center, in the rostral pontine tegmental
region, which represents the unique and specific projection from
the brainstem to the sacral MNs (Fowler et al., 2008; Holstege,
2016). POSC maintains direct projections through the entire
length of the spinal cord to the parasympatheticMNs in the sacral
segments (Holstege, 2016), controlling the detrusor muscle of the
bladder and other pelvic organs (Fowler et al., 2008). Micturition
control is also strictly related to emotions, therefore requiring the
involvement of the limbic system. Indeed many brain regions
(taking part in or connected to the limbic system) have the
important role to verify the safety of the environment where
the micturition takes place, eventually preventing it when the
optimal conditions are not guaranteed, even if signals to urgently
empty the bladder come from the sacral cord. This conflict can
strongly influence human social behavior, causing embarrassing
related to wetting pants, both in childhood and in the elderly (for
an extensive review see Holstege, 2005).
Moreover, collateral fibers of POSC have synapse to the
inhibitory premotor interneurons in the spinal cord that
are connected with Onuf’s MNs, so that contraction of the
bladder, rectum, and uterus occurs together with the relaxation
of the pelvic floor striated muscles, which is physiologically
important for micturition, defecation and delivery, respectively
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FIGURE 3 | Schematic summary of the higher-order projections to Onuf’s
nucleus. Onuf’s nucleus (ON) receives direct projections from the
paraventricular hypothalamic nucleus (Pa; in blue). The periaqueductal gray
(PAG) in the mesencephalon controls the pelvic floor by stimulating the pelvic
organ stimulating center (POSC; in red), which in turn projects to inhibitory
interneurons in the sacral cord that finally innervate Onuf’s nucleus. Moreover,
PAG sends efferent fibers to the nucleus retroambiguus (NRA; in green) in the
medulla, which is then connected with Onuf’s MNs, which innervate the
muscles determining the abdominal pressure. The strongest afferents to the
PAG originate from different brain areas (identified in purple), such as the
medial orbitofrontal cortex (OFC), the anterior cingulate gyrus (Cg), the
preoptic area and hypothalamus (POA, Hyp), the lateral Bed Nucleus of Stria
Terminalis (BNST) and the Central Nucleus of the Amygdala (CeA). Finally,
projections from the limbic system and prefrontal cortex reach the PAG that
then projects to the pelvic floor stimulating center (PFSC; in yellow) in the
pons, which in turn innervates Onuf’s MNs.
(Fowler et al., 2008; Holstege, 2016). Tracers injected into specific
hypothalamic nuclei were anterogradely transported to the
terminals reaching the spinal nuclei involved in pelvic functions
(de Groat, 2017): indeed, tracers into the paraventricular nucleus
reached the sacral parasympathetic nucleus as well as the Onuf’s
nucleus (Argiolas and Melis, 2005). Moreover, the preoptic area
and the lateral hypothalamus send projections to POSC (Kuipers
et al., 2006; Holstege, 2016). Neurons in the POSC in turn project
primarily to the sacral parasympathetic nucleus, the lateral edge
of the dorsal horn, and the dorsal commissure. Conversely,
projections from neurons in the lateral pons, a region involved in
the control of the urethral sphincter, terminate rather selectively
in the Onuf’s nucleus (de Groat, 2017).
However, the strongest afferent projections of the
POSC originate from the periaqueductal gray (PAG) in
the mesencephalon, which also projects to the pelvic
floor stimulating center (PFSC). For instance, once that
the PFSC sends inputs to void the bladder, PAG activates
the POSC neurons, whose efferent fibers directly activate the
parasympathetic preganglionic neurons in the intermediolateral
cell column of the sacral spinal cord, leading to detrusor
muscle contraction. At the same time, POSC neurons activate
GABAergic spinal interneurons leading to Onuf’s nucleus
inhibition, which results in relaxation of the striated EUS (Arya
and Weissbart, 2017). Interestingly, through the sacral pelvic
organ spinal relay center, PAG receives feedback information
concerning the urine amount in the bladder and pelvic organ
situation, generally via long ascending fiber pathways, thus
modulating pelvic muscle state through the control of POSC.
PAG projects also to the NRA in the ventrolateral tegmentum of
the caudal medulla, that, in turns, at least in several mammals
(e.g., cats), projects to the MNs of Onuf’s nucleus that innervates
the pelvic floor muscles for sexual behavior control (Holstege
and Tan, 1987; Holstege, 2016). The NRA projections to the
pelvic floor muscles controlled by Onuf’s MNs might be also
part of a system that regulates abdominal pressure (Holstege
and Tan, 1987). Finally, PAG receives fibers from other brain
regions: hypothalamus, preoptic area, amygdala, bed nucleus of
the stria terminalis, and the medial orbitofrontal cortex (OFC;
Holstege, 2016). These latter projections seem to have a strong
impact on the PAG-POSC pathway activation. Indeed, this
part of the prefrontal cortex might be considered as the output
cortical center, where the activation of POSC and Onuf’s nucleus
via PAG is decided, to regulate micturition and/or defecation
and other sexual behaviors. Interruption of this pathway leads
to loss of central control of when to start micturition, resulting
in incontinence (Holstege, 2016). Despite the POSC influences
subcortical and cortical regions (e.g., hypothalamus, locus
coeruleus, PAG, and the medial prefrontal cortex; Michels
et al., 2015; Malykhina, 2017) and several micturition centers
are located in the cerebral cortex, basal ganglia, and brainstem
(Fowler et al., 2008), no direct cortical projections to Onuf’s
nuclei have been demonstrated in humans (Iwatsubo et al.,
1990; Mannen, 2000); conversely, they were observed in South
America monkey Saimiri, in which corticospinal projections
start from the tail portion of cortical area 4 and end bilaterally
on Onuf’s nuclei (Nakagawa, 1980). Thus, the supraspinal
regulation of pelvic tract function depends on multiple paths
carrying information between the brain and the spinal cord.
Onuf’s neurons mainly display an ellipsoid shape (44%),
and more rarely a circular (37%) or fusiform (19%) shape
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(Pullen et al., 1997). As the somatic motor neurons (MNs),
Onuf’s MNs are multipolar and show large Nissl granules.
However, their cell size is smaller compared to the surrounding
MNs. Additionally, electron microscopic studies showed that the
surrounding neuropil is characterized by few myelinated fibers
and numerous vertical unmyelinated fibers arranged as dendritic
bundles (Schrøder, 1981; Mannen, 2000): this could explain the
appearance of Onuf’s nucleus in a Nissl stain.
Pullen et al. (1997) performed several morphological analyses
that allowed defining its dimension and the number and size
of neurons. In some cases, these results (although referring to a
few subjects and not statistically significant) highlighted a slight
sexual dimorphism. For example, the Onuf’s nucleus volume
was 0.299 ± 0.0369 mm3 in males and 0.285 ± 0.0551 mm3 in
females; the mean number of MNs was 654 ± 141.8 in males and
610 ± 142.7 in females; on the other hand, the mean neuronal
size was very similar between sexes (25.94 ± 3.63 µm in males,
and 26.25 ± 2.25 µm in females).
The slight sex dimorphism could depend on androgens:
following androgen deprivation, MNs die by apoptosis, whereas
the presence of androgens allowsMN survival, either primarily or
secondarily (i.e., due to muscle atrophy). This could be ascribed
to the direct action of androgens on neurons: for example,
compared with other striated muscles, MNs of bulbospongiosus
muscle can accumulate testosterone (Little et al., 2009) and
their target muscles are enriched for androgen receptors
in male (Jordan et al., 1997). Notably, androgens can also
stimulate muscular fibers to secrete the Ciliary Neurotrophic
Factor (CNTF) that retrogradely reaches MN cell bodies and
supports MN survival (Forger et al., 1993). Our group also
demonstrated the involvement of testosterone: indeed, the
prepubertal castration can determine a significant reduction in
the somatic and nuclear areas of Onuf’s nucleus MNs, although
sparing their number (Vercelli and Cracco, 1990). Additionally,
also the neuromuscular endplate area in the ischiocavernosus
muscle seems to depend on the presence of testosterone,
remaining smaller in castrated rats compared to normal




The first morphological/cytochemical studies made difficult
the classification of Onuf’s nucleus: indeed, the combination
of retrograde tracing with immunocytochemistry staining
has initially proposed the Onuf’s nucleus as a somatic
nucleus. However, due to its peptidergic inputs, it was later
suggested that Onuf’s nucleus shares also autonomic-like
features (Kawatani et al., 1986; Katagiri et al., 1988; Tashiro
et al., 1989a,b). Interestingly, Onuf’s nucleus is spared in
diseases in which somatic sacral MNs degenerate [as Duchenne
Muscular Dystrophy (DMD), Spinal Muscular Atrophy (SMA)
and Amyotrophic Lateral Sclerosis (ALS)]; on the contrary,
the nucleus is affected -together with the parasympathetic
nuclei in pathologies in which somatic sacral MNs are
spared [such as Shy-Drager Syndrome (SDS), Fabry’s disease,
Parkinson’s Disease (PD) and Multiple System Atrophy (MSA)].
The first group of diseases is characterized by somatomotor
neuronal disorders, while the second group mainly includes
visceromotor neuronal malfunctions. Thus, this characteristic
is rather an indication for its dual instead of a unique
autonomic nature.
Indeed, Onuf’s nucleus and somatic MNs share some
electrophysiological properties. On the other hand, different
passive electrical membrane properties have been described,
together with low rheobase values (Hochman et al., 1991; Sasaki,
1991); moreover, despite collateral axons are recurrent (Sasaki,
1994), Onuf’s MNs miss recurrent inhibition (Jankowska et al.,
1978; Sasaki, 1991).
Thus, this evidence suggests that the real nature of Onuf’s
MNs should be investigated biochemically, to better define
their specificities and to clarify their involvement in the
abovementioned pathologies. The neurochemical properties of
Onuf’s neurons have been initially studied since the later ‘80s.
It has been demonstrated, in both human and laboratory
animals, that Onuf’s nucleus is densely innervated by CPON-
(C-terminal Flanking Peptide of Neuropeptide Y), enkephalin-
and somatostatin-immunopositive fibers, suggesting an
autonomic nature of these cells. In specific areas of the neuropil,
dense aggregates of peptide-immunoreactive fibers are visible in
the proximity of Onuf’s nucleus (Gibson et al., 1988; Katagiri
et al., 1988; Pullen et al., 1997). Indeed, the density of enkephalin-
immunopositive varicosities is higher than over somatic neurons
(Ramírez-León et al., 1994), and enkephalin fibers outline Onuf’s
nucleus (Gibson et al., 1988). Varicose CGRP peptide-positive
fibers are observed in spinal laminae VII–IX and in association
with the neurons of Onuf’s, together with CPON-positive
fibers that appear numerous around Onuf’s cells. Additionally,
some neurons of Onuf’s nucleus are innervated by neurokinin-
like-immunoreactive fibers. A strikingly dense innervation of
somatostatin-positive fibers is observed, whereas no Thyrotropin
Releasing Hormone (TRH)-positive elements are visible around
Onuf’s neurons. Finally, small numbers of Vasoactive Intestinal
Polypeptide-immunoreactive fibers are found associated with
Onuf’s nucleus (Gibson et al., 1988; Katagiri et al., 1988), and
dopamine beta-hydroxylase (DBH)-immunoreactive fibers were
described in rat Onuf’s nucleus by Kojima et al. (1985).
Thus, since innervation, peptide pattern distribution and
neuronal integrity are lost in somatic MN diseases (such as
ALS), and conversely spared in Onuf’s nuclei, it could be
speculated that the pattern of innervation and peptide expression
contributes to the maintenance of Onuf’s neural integrity
(Gibson et al., 1988).
Similarly, both muscle fiber composition and innervation
could influence the selective vulnerability of MNs. As known,
muscle fibers can be divided into fast-twitch glycolytic (type IIb),
fast-twitch oxidative (type IIa), and slow-twitch oxidative (type I)
groups. Histochemical and morphometrical analyses on human
bulbospongiosus and ischiocavernosus muscles (innervated by
Onuf’s MNs) revealed a high variability of the distribution of the
two fiber types, with type I fibers abundantly expressed, especially
in ischiocavernosus muscle (Ravnik and Sirca, 1993). Moreover,
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the oxidative activity was higher in type I fibers, which notably
are usually smaller in diameter than type II (Schrøder and Reske-
Nielsen, 1983; Ravnik and Sirca, 1993).
Finally, also non-cell-autonomous events could contribute
to the progression of MN diseases. For instance, astrocytes
in sporadic ALS samples appear harmful to somatic MN
survival (Haidet-Phillips et al., 2011), whereas Onuf’s MNs
and oculomotor nuclei seem less vulnerable to toxic astrocytes.
Indeed, it is still unclear if either: (i) these MNs are more
resistant to neuroinflammation per se; or (ii) the astrogliosis
is less intense around these resistant nuclei; or (iii) astrocytes
surrounding Onuf’s nucleus differently react to degeneration
(Nijssen et al., 2017).
RECENT INSIGHTS FROM GENOMICS
AND PROTEOMICS
The differential vulnerability of Onuf’s neurons has been initially
attributed to their cytoarchitecture, connectivity, and metabolic
rate (Onuf, 1899; Schrøder, 1981; Gibson et al., 1988; Shaw and
Eggett, 2000). Only recently, in the XXI century, it has been
evaluated by more sophisticated genetic and molecular analyses
(Kaplan et al., 2014; Allodi et al., 2019).
The first evidence comes from studies on the ontogeny of
MNs, which is led by differential expression of transcription
factors guiding neuronal differentiation and diversification
during embryogenesis (Cave and Sockanathan, 2018).
Concerning the Onuf’s neurons, the LIM homeodomain
protein Islet-1 seems involved in their embryonic generation:
indeed, in the murine spinal cord, at embryonic days 13.5–15.5,
the highest expression of Islet-1 is reported in MNs innervating
EUS and ischiocavernosus muscles, and to a lesser extent in the
sacral parasympathetic preganglionic neurons. These findings
suggest that Onuf’s neuron development can be guided in a
distinct transcriptional way compared to other MN groups at the
prenatal stages (Han et al., 2009).
Valuable insights into the resistant/vulnerable nature of
specific MN pool also came from another cell population,
i.e., oculomotor neurons, which share many commonalities
with Onuf’s neurons and are similarly spared in some
pathologies (as ALS and SMA). Pioneering transcriptome
studies revealed hundreds of genes differentially enriched in
the oculomotor neurons, including insulin-like growth factor
II and guanine deaminase, playing a pivotal neuroprotective
function against glutamate-induced neurotoxicity (Hedlund
et al., 2010). Accordingly, in 2013, microarray analysis
demonstrated that human oculomotor neurons show a
distinct transcriptional profile, compared to somatic spinal
MNs. Indeed, approximately 1,700 genes (mainly related
to synaptic transmission, ubiquitin-dependent proteolysis,
mitochondrial activity, and transcriptional regulation) resulted
differentially expressed: in particular, the reduced susceptibility
to excitotoxicity of these neurons seems to play an important
role in assuring resistance to neurodegeneration (Brockington
et al., 2013).
More recently, Kaplan et al. (2014) studied in ALS mice the
gene expression profile of both Onuf’s and oculomotor nuclei,
compared to vulnerable spinal MNs. The authors performed
a microarray profiling of MNs isolated from P7 WT or ALS
mice, to identify the selective genetic signature of Onuf’s and
oculomotor nuclei (resistant in ALS) and lumbar spinal MNs
(vulnerable; Kaplan et al., 2014). The authors found 18 genes
more than ten-folds differentially expressed in vulnerable than in
resistant MNs and identified 14 of these genes expressed only in
the vulnerable ones. Moreover, they showed that Semaphorin3a
(SEMA3A), Glutamate decarboxylase 2 (GAD2) and potassium
voltage-gated channel subfamily J member 5 (KCNJ5) genes were
enriched in oculomotor and Onuf’s nuclei, whereas Natriuretic
Peptide Receptor 3 (NRP3), TRHReceptor (TRHR), Neurotensin
(NTS), Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3),
17β-Hydroxysteroid dehydrogenase 2 (HSD17B2) and MMP9
(matrix metallopeptidase 9) genes were depleted in the resistant
population of Onuf’s and oculomotor MNs. In particular,
MMP9 was strongly expressed by the majority of cranial
and spinal MNs, and undetectable in Onuf’s nucleus. Thus,
MMP9 can represent a prospective marker for ALS-affected
MNs, also because its high expression can be detected even in
the neonatal spinal cord, before the earliest known functional
changes occurring in ALS (Kaplan et al., 2014; Nijssen et al.,
2017). Indeed, reduction or deletion of MMP9 delay muscle
denervation and extend the survival of transgenic mice (Kaplan
et al., 2014). The extracellular matrix protein osteopontin
(OPN) is selectively expressed by ALS-resistant MN pools,
and the difference in OPN/MMP9 expression profiles in MN
populations could partially explain the selective vulnerability
of cells in neurodegeneration. OPN is involved in the second
wave of neurodegeneration in ALS disease by upregulating
MMP9 through αvβ3 integrin (Morisaki et al., 2016).
Recently, Allodi et al. (2019) isolated Onuf’s MNs from
human post-mortem tissue, together with oculomotor and spinal
(from cervical and lumbar segments) MNs, and analyzed
their marker expression by spatial transcriptomic method
LCM-seq. While all MN groups expressed high levels of
neurofilaments (NFs) and Vesicular acetylcholine transporter
(VACHT), Onuf’s MNs selectively and uniquely expressed
349 up- and 572-downregulated expressed genes (DEGs).
Interestingly, gene ontology analysis revealed that those genes
enriched in Onuf’s neurons are involved in trans-synaptic and
anterograde synaptic signaling, ATP biosynthesis processes,
regulation of neurotransmitter levels, regulation of exocytosis
and synaptic vesicle localization. The study also revealed that
oculomotor and Onuf’s MNs mainly showed distinct gene
pattern regulation, even if some common pathways were
identified. Indeed, the authors found that Onuf’s and oculomotor
MNs shared 214 DEGs, of which 142 were downregulated
and 58 upregulated compared to spinal MNs, and 14 genes
were regulated in opposite direction in the two nuclei. The
common pathways could underlie the joint resilience of Onuf’s
and oculomotor nuclei in spinal neurodegenerative diseases. For
instance, MIF (macrophage migration inhibitory factor), which
has been demonstrated to be neuroprotective in ALS (Shvil
et al., 2018), showed a high expression both in Onuf’s and
oculomotor nuclei compared to the other spinal MNs (Allodi
et al., 2019). Instead, among the 14 opposite-regulated genes,
Frontiers in Neuroanatomy | www.frontiersin.org 5 September 2020 | Volume 14 | Article 572013
Schellino et al. Morpho-functional Features of Onuf’s Nucleus
some are involved in neurogenesis and apoptosis regulation
(Ephrin type-A receptor 7, sparc/osteonectin1), in the regulation
of proteins associated with the cytoskeleton (PDZ and LIM
Domain 1), in the degradation of transmembrane proteins (Ras-
related protein RAB12), in the stabilization of cell membrane
potential and maintenance of intracellular pH (CLIC1) and
in receptor assembly and activity (e.g., Progestin and AdipoQ
Receptor Family Member 8, gamma-aminobutyric acid type A
receptor alpha1 subunit, Gamma-Aminobutyric Acid Type A
Receptor Subunit β1; Allodi et al., 2019).
These studies demonstrated that gene and/or protein
expression analysis of MNs that show differential susceptibility
to degeneration can be used to point out candidates to
preserve vulnerable MNs. The studies highlight that neuronal
vulnerability in the spinal cord could be regulated by the
lack of certain beneficial factors and proper innervation, as
well as by the increase in susceptibility to noxious molecules
(Nijssen et al., 2017).
INVOLVEMENT OF ONUF’S NUCLEUS IN
DISEASES
For its peculiarities, Onuf’s nucleus is involved or affected
in aging-related pathologies as well as several traumatic and
neurodegenerative disorders (as PD and SDS), whereas it is
spared in other diseases (ALS, SMA, DMD) that we describe
below (Figure 4). Although extremely important in pediatrics,
here we will not deal with the Onuf’s nucleus development and
related defects.
Urinary Incontinence and Aging
Micturition is allowed by the contraction of the detrusor
muscle of the bladder and by the coordinated relaxation of
two urethral sphincters: the external sphincter (also known as
urogenital sphincter) and the internal sphincter (a.k.a. trigone
sphincter), that are respectively innervated by voluntary and
autonomic control (reviewed by Jung et al., 2012). Accordingly,
the urethra wall receives the innervation by both autonomic and
somatic nervous system: (i) the sympathetic and parasympathetic
innervation is dedicated to the longitudinal and circular smooth
muscle layers in the urethra, whereas (ii) the somatic innervation
(involving the Onuf’s nucleus) through the pudendal nerve is
dedicated to the striated muscle rhabdosphincter (Thor, 2004).
The cerebral cortex, POSC, and the thoracic, lumbar, and
sacral spinal regions control the lower urinary tract. In particular,
as described above, the prefrontal cortex, through the medial
OFC with its projections to the PAG, plays an important role in
micturition (Holstege, 2016).
The degeneration of the above-mentioned pathways leads
to urge-urinary incontinence (UI) in patients, due to altered
communication between cortex, PAG-POSC, and Onuf’s
nucleus. In this case, the PAG activates micturition function
based only on incoming information from the pelvic organs
(without the cortical control): thus, only a relatively small
amount of urine is sufficient to activate the pathway, leading
to uncontrolled micturition (Holstege, 2016). Aging, obesity,
multiple labors, and prostatic surgery could lead to UI.
Additionally, stress urinary incontinence (SUI) is characterized
by the leakage of urine because of an effort, a physical exercise,
or sneezing/coughing (Haylen et al., 2010).
The current treatments for SUI involve behavioral therapy,
pelvic floor muscle training, pharmacological treatment, and
surgery (including urethral bulking injections; Padmanabhan
and Dmochowski, 2014). However, the surgical approach can be
associated with complications or poor effectiveness. Besides, also
stem cell therapy has been evaluated as a promising treatment
(Gunetti et al., 2012; Gallo et al., 2019).
It has been described that serotonin and noradrenaline are
involved in the central neural control of the lower urinary tract
function: the pudendal somatic motor nucleus of the spinal cord
is densely innervated by serotonin (5-HT) and norepinephrine
(NE) terminals. 5-HT is released from the raphe nuclei in the
brainstem and binds to different receptors (5-HT1A, 5-HT2A,
5-HT2C, 5-HT3, and 5-HT7; as reviewed by Panicker, 2019).
Indeed, Xu et al. (2007) described in the rat Onuf’s nucleus the
presence of several groups of MNs innervating different pelvic
striated muscles: these neurons differentially express 5-HT2AR
and 5-HT5AR. In particular, 5-HT2ARs are mainly localized
in MNs innervating the ischiocavernosus muscle, whereas
5-HT5ARs are specifically expressed in neurons innervating the
external urethral sphincter and bulbospongiosus muscles (Xu
et al., 2007). Serotonin and noradrenaline modulate the effect
of the neurotransmitter glutamate, which in turn activates the
neurons in the Onuf’s nucleus, resulting in the contraction of the
sphincters (Michel and Peters, 2004; Panicker, 2019). In general,
serotonergic receptor agonists exert a pro-continence effect by
suppressing parasympathetic activity and increasing somatic and
sympathetic activity in the lower urinary tract (Michel and Peters,
2004). Drugs, as duloxetine, can act by blocking the 5-HT and
NE reuptake and by increasing the receptor activation at the
presynaptic neuron in Onuf‘s nucleus of the sacral spinal cord:
as a consequence, the sphincter MN activity is increased (Jost
and Marsalek, 2004) and the control of urine storage/micturition
improved (Thor, 2004).
Similarly, aging (characterized by changes in central
monoaminergic neurons) can cause urinary dysfunction.
Quantitative image analysis revealed significant age-associated
declines in the innervation of the intermediolateral nucleus,
sacral parasympathetic nucleus, dorsal gray commissure, and
Onuf’s nucleus (Ranson et al., 2003). Studies on aged rats
revealed that mean and maximal micturition volumes are
significantly larger compared to young animals (Chun et al.,
1988), due to changes in the innervation of the bladder and
central control of micturition. In 2010, Zhao and colleagues
(Zhao et al., 2010) confirmed that ‘‘in old rats, the bladder
capacity and the post-void residual urine are higher, and
responses to muscarinic receptor stimulation and electrical
field stimulation are lower than in young rats.’’ These findings
correlate with observations from aged human bladders, in whom
decreased detrusor contractility and detrusor overactivity are
among the most conspicuous age-related changes in bladder
function (Hald and Horn, 1998).
Indeed, urinary incontinence is also reported in the case
of Alzheimer’s disease (AD) and dementia with Lewy bodies,
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FIGURE 4 | Selective vulnerability of Onuf’s MNs. (A) Onuf’s nucleus is affected in several neurodegenerative diseases, such as Parkinson’s disease (PD) and
multiple system atrophy (MSA) Parkinsonism, the progressive supranuclear palsy (PSP), the Shy-Drager-Syndrome, and Fabry’s disease. Onuf’s MNs are also
degenerating in aging-related pathologies, leading, for instance, to urinary incontinence. (B) On the contrary, Onuf’s nucleus is spared in certain neurodegenerative
diseases where, conversely, somatic MNs are degenerating: for instance, Onuf’s MNs are preserved in amyotrophic lateral sclerosis (ALS), spinal muscular atrophy
(SMA), and duchenne muscular dystrophy (DMD). Dotted lines represent dying/affected MNs.
due to detrusor overactivity (Del-Ser et al., 1996; Ransmayr
et al., 2008). This is probably due to pathologic changes in
the frontal cortex and substantia nigra (Attems et al., 2007;
Ransmayr et al., 2008); moreover, supra-pontine lesions resulting
from AD can affect the cortical inhibitory control of POSC
(Yokoyama et al., 2002).
Spinal Cord Injury
A spinal cord injury (SCI) induces damage at the level of the
spinal cord that causes temporary or permanent changes in
neuronal function and innervation. Symptoms include loss of
sensations, paralysis, or autonomic dysregulation, below the level
of the injury (Eckert and Martin, 2017).
Therefore, SCI can also affect Onuf’s MNs and their
innervation of the EUS muscle: indeed, in case of trauma above
the lumbosacral level, EUS fails to relax while the bladder is
contracting, leading to voiding impediment, urine retention,
bladder pressure, finally causing renal failure (Weld et al.,
2000; de Groat and Yoshimura, 2006; Ni et al., 2019). More
in detail, after SCI, the serotoninergic nerve fibers start to
degenerate below the level of injury (Ni et al., 2019); then, a
significant increase in the number of 5-HT7 receptors (5-HT7Rs)
in the Onuf’s nucleus has been observed in SCI rat models,
together with dysfunctions in urethra opening and closing
(Gang et al., 2014; Ni et al., 2019; Panicker, 2019). By injecting
intrathecally in SCI rats a selective agonist for 5-HT7R, Ni
and colleagues obtained a significant dose-dependent increase
in micturition volume and voiding efficiency (Ni et al., 2019).
The change in the expression of serotonin receptors after SCI
must be confirmed in human Onuf’s cells, but these recent
findings suggest the 5-HT7R could be a possible target for
therapeutic interventions.
Moreover, in men, Onuf’s neurons also innervate the striated
perineal muscles attached to the base of the penis (Breedlove and
Arnold, 1980), thus being involved in ejaculation functions and
subsequent sexual behavior. SCI at this spinal level frequently
leads to sexual dysfunction in men, including erectile and
ejaculation disorders (Chéhensse et al., 2013; Sakamoto, 2014;
Krassioukov and Elliott, 2017). In patients with complete injuries
of S2-S4 segments, a rhythmic forceful ejaculation is precluded;
moreover, urine leaks due to urinary sphincter hypotonia or
atonia are often reported. These data support the idea that the
parasympathetic and somatic centers located in S2-S4 segments
control the emission and expulsion phases of ejaculation in men
(Chéhensse et al., 2013): in particular, Onuf’s nucleus participates
in ejaculation, innervating the bulbospongiosus muscle and
consequently favoring the semen progression from the bulbar to
the penile urethra (Gerstenberg et al., 1990).
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Moreover, the nervous pathway for the voluntary control
of fecal continence and defecation also involves the Onuf’s
nucleus. Defecatory disorders (e.g., difficulties in defecation,
fecal incontinence, and chronic constipation) are common
severe problems in SCI patients and are generally attributed
to a dysfunctional control of peristalsis and colorectal motility
by the CNS (Lynch and Frizelle, 2006). In SCI condition, the
interactions between the somatic and autonomic components
are compromised: indeed, spinal cord trauma leads to a failure
of supraspinal inputs modulating the lumbosacral defecation
centers and the Onuf’s nucleus, affecting voluntary motor
functions and uncoordinated anorectal reflexes (Guertin,
2016). In particular, descending fibers from the brainstem
lateral cell group make synapses on those Onuf’s MNs
that supply the external anal sphincter (Callaghan et al.,
2018). To preserve continence, afferents to the rectum start
contractions of the external anal sphincter through spinal
reflexes, and consistent with the presence of local reflex
control of the external sphincter, connections are made
to Onuf’s nucleus from the spinal afferents and the sacral
regions of the defecation center. Some of these local inputs
to Onuf’s nucleus are inhibitory (Beckel and Holstege, 2011;
Callaghan et al., 2018). Moreover, there is some evidence
in humans that spinal circuits can influence the external
sphincter independently of brain descendent pathways
(Broens et al., 2013).
Parkinson’s Disease and
Parkinsonian-Like Syndromes
PD is a severe neurodegenerative pathology due to the
progressive loss of dopaminergic neurons in the substantia nigra,
determining tremors, bradykinesia, rigidity, impaired posture
and balance (Beitz, 2014).
Among the commonest non-motor symptoms in PD, urinary
urgency, increased daytime frequency, and nocturia is reported
(Sakakibara et al., 2012). These bladder symptoms are probably
a consequence of the cell death in the substantia nigra causing
progressive loss of the D1 receptor-mediated tonic inhibition
of the micturition reflex, which in turn leads to detrusor
muscle hyperactivity (Winge and Fowler, 2006). Indeed, the
disruption of the suprapontine circuitry eliminates the inhibitory
control over the POSC, decreasing bladder capacity, and causing
detrusor overactivity (Fowler et al., 2008).
Alterations at the Onuf’s nucleus level have been clinically
reported for the first time in 2008, in a 59 year-old PD
patient (O’Sullivan et al., 2008): in this patient, deterioration
into a hypo-compliant bladder, with subsequent evidence
of obstructions and bladder instability, worsened together
with PD progression. The analysis of the patient nervous
tissue revealed the accumulation of a-synuclein-positive
Lewy bodies not only in the substantia nigra, the cortex,
and brainstem but also in the spinal cord. Indeed, scattered
Lewy neurites and Lewy bodies were found in the gray
matter of the intermediolateral columns of the spinal
cord, at the thoracic and sacral levels, including the Onuf’s
nucleus. Generally, PD patients do not show severe sphincter
abnormalities in the early stages of the disease, whereas
some cases of neurogenic changes of external anal sphincter
muscle have been observed in advanced stages of PD
(Libelius and Johansson, 2000; O’Sullivan et al., 2008).
The neurodegeneration of Onuf’s nucleus is one of the
pathological landmarks found in MSA Parkinsonism (MSA-P)
disease. Indeed, many cases of MSA-P are characterized by
the almost complete neuronal degeneration in Onuf’s nucleus,
associated with progressive loss in urinary function: Onuf’s
impairment is considered as responsible for denervation of
the urethral sphincter and external anal muscles observed
in MSA-P (Yamamoto et al., 2005; O’Sullivan et al., 2008).
The involvement of Onuf’s nucleus in the progression of
the disease seems to be time-dependent, in the early phases
of the disease, no signs of neurogenic changes are detected,
while pathological signs become progressively evident with the
increasing incontinence (storage and voiding disorders) and in
detrusor muscle over-activity (Yamamoto et al., 2005, 2014).
Autonomic urinary dysfunction has been described also in
patients with Progressive Supranuclear Palsy (PSP), a rare brain
Parkinson-like disorder that causes progressive problems in gait
and balance (Yamamoto et al., 2016). In PSP patients, urinary
storage dysfunctions are not different from that of PD and
MSA-P, whereas urinary voiding dysfunction in PSP results more
severe than in PD, while milder than in MSA-P (Yamamoto
et al., 2016). The Onuf’s nucleus degeneration in PSP remains
to be clarified. Three cases of Onuf’s neuronal loss have been
reported by Scaravilli et al. (2000) in PSP patients with clinical
evidence of sphincter disturbances. In these patients, together
with neuropathological changes in cortical, subcortical, and
autonomic centers already described for PSP (Kasashima and
Oda, 2003; Halliday et al., 2005), neurofibrillary tangles were
observed across the spinal cord, through the intermediolateral
columns and Onuf’s nuclei. Besides, neuropil threads and glial
inclusions were also observed in Onuf’s nucleus region (Scaravilli
et al., 2000). Moreover, the nucleus displayed a severe cell loss:
morphological and morphometrical analyses showed a reduction
of more than 50% in the number of MNs, together with the
reduction in cell diameters compared to healthy conditions
(Scaravilli et al., 2000).
Conversely, other works based on quantitative motor unit
potential (MUP) analysis did not reveal any alteration in
Onuf’s nucleus related to bladder dysfunction in PSP patients
(Yamamoto et al., 2016). They found that the mean value of
MUPs in PSP patients showed a duration (less than 10 ms) that
does not indicate neurogenic changes in Onuf’s nucleus. MUP
duration reflects the progression of frontal cortex degeneration
in PSP patients, but the neurodegeneration in Onuf’s nucleus
might be occurring in parallel (Yamamoto et al., 2016).
However, the rarity of the disease and the limitation in PSP
(spinal) sample availability might constitute a restriction in PSP
pathophysiological studies and large cohorts of patients are
needed to better unravel the involvement of Onuf’s nucleus.
Shy-Drager Syndrome and Fabry’s Disease
SDS is a movement disorder that can be referred to as a
PD plus MSA. SDS patients show rigidity and bradykinesia
as primary extrapyramidal symptoms, together with autonomic
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nervous system dysfunctions which lead to much of the disability
seen in this disorder. Indeed urinary incontinence, syncope,
constipation, fecal incontinence, cardiac arrhythmias as well as
other symptoms are the result of the widespread pathological
changes occurring in multiple areas of the central and autonomic
nervous system in SDS (Hodder, 1997). Since early stages, SDS
patients show loss of sphincter tone as well as fecal and urinary
incontinence compatible with chronic denervation (Shy and
Drager, 1960; Sung et al., 1979).
A general alteration at the spinal cord level is observed:
sacral cross-sections are smaller in size than the healthy controls
and the anterior median fissure appears slightly widened at the
levels Sl-S3. Moreover, MNs in the ventral horns are decreased
in number: the posteromedial and posterolateral groups are
the most highly affected compared to the anteromedial and
anterolateral groups. Onuf’s nucleus appears atrophied and
without the peculiar paleness of the neuropil. Indeed, histological
analysis revealed that in many SDS cases the neurons of Onuf’s
nucleus are almost entirely lost (Sung et al., 1979; Mannen
et al., 1982). Together with this selective neuronal loss, SDS is
also characterized by marked abnormalities in the external anal
sphincter muscle, characterized by thickness reduction, increase
in sarcolemmal nuclei number and in endomysial connective
tissue (as signs of neurogenic muscular atrophy; Mannen, 1991).
Alterations in Onuf’s nucleus have been also observed
in other pathologies involving multiple systems, with major
dysfunctions in the autonomic nervous system. For instance,
Fabry’s Disease (FD) is an X-linked lysosomal storage disorder
due to a deficiency in α-galactosidase-A activity; this leads to
the subsequent accumulation in various tissue and organs of
the globotriaosylceramide (Gb3) substrate, which contributes
to disease pathology (Sung, 1979; Khanna et al., 2010).
The nervous system is particularly affected, and interestingly,
neuronal lipid storage is limited to certain nuclei, such as
the amygdala, hippocampus, hypothalamus, substantia nigra,
reticular formation of the brainstem, ambiguus and dorsal vagal
nuclei of the medulla oblongata and the lateral horns of the
spinal cord (Sung, 1979). Indeed, it was observed that autonomic
centers throughout the neuro-axis show a predilection for
lipid storage, thus representing a landmark marker of FS
disease: due to these lipid depots, Onuf’s neurons acquire a
typical ‘‘ballooned’’ morphology (Sung, 1979). Interestingly, the
accumulation of Lewy bodies was recently observed in many
areas of the brain and in the spinal cord lamina IX of an FS
patient (Del Tredici et al., 2020): this suggests that amore detailed
analysis of human FD spinal cord might reveal the presence of
pathological inclusions also in the Onuf’s nucleus.
Amyotrophic Lateral Sclerosis and Spinal
Muscular Atrophy
ALS is a neurodegenerative disease targeting the upper and
lower somatic MNs, which innervate voluntary muscles, leading
to muscle atrophy and weakness of skeletal muscles. MNs
of the autonomic system is less affected (Piccione et al.,
2015). Approximately 10% of ALS cases are familial (fALS),
while 90% are sporadic (sALS). Mutations have been identified
in more than 20 genes (e.g., Superoxide dismutase 1) and
contribute to the two-thirds of fALS and for about 10% of sALS
(Chia et al., 2018). Moreover, many complex and correlated
pathological mechanisms (such as mitochondrial dysfunction,
protein aggregation, excitotoxicity, and inflammation) have
been identified as contributors to MN malfunction and death
(Robberecht and Philips, 2013).
Interestingly, subtypes of affected spinal MNs display a
gradient of vulnerability, with fast-twitch fast-fatigable (FF) MNs
degenerating before slow MNs, while specific MN pools are
more resistant to neurodegeneration, such as the oculomotor
neurons and neurons of the Onuf’s nuclei (Nijssen et al., 2017).
Consequently, muscle denervation occurs early on type IIb
muscle fibers, mainly innervated by FF MNs, followed by a
second wave of denervation affecting the type IIa muscles, due
to the degeneration of fatigue-resistant MNs (Frey et al., 2000;
Kaplan et al., 2014). Instead, the slow MNs are resistant almost
until the disease end-stage, still providing the innervation of
type I fibers (Rochat et al., 2016). Muscles innervated by Onuf’s
MNs might result in more resistance to denervation due to
the higher percentage of small type I muscle fibers, compared
to other skeletal muscles; the presence of slow MNs in Onuf’s
nucleus could partially explain Onuf’s neuron resilience in some
neurodegenerative diseases.
Indeed, given the peculiar characteristics of Onuf’s and
oculomotor MNs described above (up/down regulation of
specific genes compared to spinal MNs as showed in Kaplan
et al., 2014; Allodi et al., 2019), it is not surprising that these
neurons respond differently in ALS compared to the other MNs,
remaining resistant to degeneration until the later stages of the
disease. For instance, as stated, it has been demonstrated that
MMP9 is highly expressed by ALS-affected spinal MNs, whereas
its expression is absent in Onuf’s neurons; on the contrary, the
protein OPN is selectively expressed by ALS-resistant pool, while
downregulated in vulnerable MNs (Kaplan et al., 2014).
Cytoskeletal abnormalities in Onuf’s nucleus have been rarely
addressed in ALS patients: sporadic atrophic neurons with
evident central chromatolysis or cells showing conglomerate
inclusions (e.g., spheroids, anti-NF positive inclusions,
ubiquitin-reactive inclusions, Bunina bodies) were infrequently
detected (Okamoto et al., 1991; Bergmann et al., 1995; Kihira
et al., 1997). By using correlative morphometry analysis, Takeda
et al. (2014) showed a decreased cell circularity index at the early
phase also in Onuf’s nucleus, although neuronal perimeter and
area of Onuf’s neurons remained stable even in advanced phases
of disease.
Given that in ALS Onuf’s nucleus is only partially vulnerable
to the ALS process and the degree of degeneration differs from
that observed in other MNs, the involvement of Onuf’s nucleus
might be slowed due to characteristics specific to this nucleus,
including its physicochemical and molecular properties.
Interestingly, also in SMA, the autosomal recessive MN
disease representing the most common genetic cause of infant
mortality, patients retain both normal eye movements and
external sphincter continence. Indeed, oculomotor and Onuf’s
nuclei are preserved in SMA as well as in ALS (Sumner et al.,
2017). Thus, the lack of Survival Motor Neuron (SMN) protein,
which is the specific hallmark of MNs in SMA pathology,
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could only partially affect Onuf’s cells. Deep transcriptomic
analysis in SMA tissues might reveal opposite-expressed genes
between Onuf’s and the spinal MNs, eventually related to
SMN function.
The most severe form of SMA (SMA type I) is also known
as Werdnig-Hoffman disease (WHD). In addition to SMN
lack, it is characterized by the presence of glial bundles in
the anterior nerve roots, with relative preservation of the
phrenic MNs and diaphragm, and the presence of ballooned
neurons immunohistochemically positive for phosphorylated NF
(Kuroiwa et al., 1997). Although these lesions mainly affect
the motor system, some studies also reported the involvement
of the cerebellum, thalamus, and other regions (Norman
and Kay, 1965). In the spinal cord, the loss of MNs in
the thoracolumbar regions is accompanied by mild fibrous
astrogliosis and loss of myelin. These characteristics appear
more striking in the lumbar segments: here, the neurons of
the intermediolateral and Clarke’s nuclei are relatively well
preserved. Instead, in the sacral segments, the neurodegeneration
together with increased astrogliosis is diffusely observed, but
Onuf’s nucleus neurons appear spared (Kuroiwa et al., 1997).
Only in rare cases (about 5%), Onuf’s neurons showed central
chromatolysis, but no differences in the number and mean
cell diameter were observed between WHD and control tissues
(Kumagai and Hashizume, 1982).
Similarly, in the case of Spinal Bulbar Muscular Atrophy
(SBMA), an X-linked disorder caused by expansion of a CAG
trinucleotide repeat in the androgen receptor (AR) gene, the
oculomotor and Onuf’s nuclei resist to neurodegeneration
(Sobue et al., 1981). It was initially proposed that the sparing of
these neurons was due to lack of ARs (Sar and Stumpf, 1977), but
further studies revealed a high expression of AR protein in Onuf’s
nucleus (Merry, 2001), ruling out this possibility.
Duchenne Muscular Dystrophy
The DMD is an X-linked neuromuscular disorder caused by
mutations in the dystrophin gene. The absence of dystrophin
protein leads to progressive muscular weakness and wasting,
causing degeneration of both skeletal and cardiac muscles
(Falzarano et al., 2015). Onuf’s nucleus appears spared in DMD
patients (Iwata and Hirano, 1978): indeed, in DMD bladder
and sphincter dysfunction are rarely reported, even in advanced
disease stages. As already observed in other diseases (e.g., ALS),
the sparing of neurons in the Onuf’s nucleus seems to limit the
fiber loss in the external urethral sphincter and, in general, in the
pelvic floor (Pullen andMartin, 1995). Some DMD patients show
a detrusor-sphincter dyssynergia, but concomitant with other
dysfunctions, such as cerebral palsy and paraplegia following
scoliosis surgery (Dyro and Bauer, 1990).
CONCLUDING REMARKS
Onuf’s nucleus is anatomically and physiologically intriguing. Its
MNs are histologically comparable to the other somatic MNs
(Onuf, 1899; Pullen et al., 1997) and innervate striated voluntary
muscles. However, curiously, Onuf neurons also show some
autonomic-like features as, for instance, they receive presynaptic
connections from the midbrain nuclei that project both to Onuf’s
and autonomic preganglionic parasympathetic neurons (Pullen
et al., 1997). Moreover, a strong peptidergic presynaptic input
associates Onuf’s nucleus with autonomic neurons (Kawatani
et al., 1986; Tashiro et al., 1989a; Pullen et al., 1997).
As described above, these peculiarities make Onuf’s nucleus
alternatively vulnerable or resistant to neurodegeneration in
different neurological diseases. Through the years, progressively
more sophisticated techniques revealed that a specific
morphological, biochemical, metabolic and genetic signature
could be responsible for their differential vulnerability/resistance
to degeneration (Onuf, 1899; Schrøder, 1981; Gibson et al., 1988;
Shaw and Eggett, 2000; Kaplan et al., 2014; Allodi et al., 2019).
Altogether, these studies pave the way to design new
therapeutic strategies for counteracting neurodegeneration.
However, as highlighted, the majority of recent data refer to
ALS. Therefore, additional analyses are still needed to better
explain the resilience/vulnerability of Onuf’s neurons in other
pathologies, seen the heterogeneity in the disease etiology and
onset, in the age of patients, in the distribution of vulnerable
motor pools (e.g., diaphragmatic function is preserved in SMA
and affected in ALS) and molecular targets.
AUTHOR CONTRIBUTIONS
MB: conceptualization and draft preparation. RS and MB:
writing, figures, and revision. MB and AV: final revision.
FUNDING
This study was supported by Ministero dell’Istruzione,
dell’Università e della Ricerca (MIUR) project ‘‘Dipartimenti
di eccellenza 2018-2022’’ and by Girotondo/ONLUS and
SMArathon-ONLUS foundations.
REFERENCES
Allodi, I., Nijssen, J., Benitez, J. A., Schweingruber, C., Fuchs, A., Bonvicini, G.,
et al. (2019). Modeling motor neuron resilience in als using stem cells. Stem
Cell Reports 12, 1329–1341. doi: 10.1016/j.stemcr.2019.04.009
Argiolas, A., and Melis, M. R. (2005). Central control of penile erection: role of
the paraventricular nucleus of the hypothalamus. Prog. Neurobiol. 76, 1–21.
doi: 10.1016/j.pneurobio.2005.06.002
Arya, N. G., and Weissbart, S. J. (2017). Central control of micturition in women:
brain-bladder pathways in continence and urgency urinary incontinence. Clin.
Anat. 30, 373–384. doi: 10.1002/ca.22840
Attems, J., Quass, M., and Jellinger, K. A. (2007). Tau and α-synuclein brainstem
pathology in Alzheimer disease: relation with extrapyramidal signs. Acta
Neuropathol. 113, 53–62. doi: 10.1007/s00401-006-0146-9
Beckel, J. M., and Holstege, G. (2011). ‘‘Neuroanatomy of the lower urinary tract,’’
in Urinary Tract, eds K. E. Andersson and M. C. Michel (Berlin: Springer),
99–116.
Beitz, J. M. (2014). Parkinson’s disease: a review. Front. Biosci. 6, 65–74.
doi: 10.2741/s415
Bergmann, M., Völpel, M., and Kuchelmeister, K. (1995). Onuf’s nucleus is
frequently involved in motor neuron disease/amyotrophic lateral sclerosis.
J. Neurol. Sci. 129, 141–146. doi: 10.1016/0022-510x(94)00263-n
Frontiers in Neuroanatomy | www.frontiersin.org 10 September 2020 | Volume 14 | Article 572013
Schellino et al. Morpho-functional Features of Onuf’s Nucleus
Breedlove, S. M., and Arnold, A. P. (1980). Hormone accumulation in a sexually
dimorphic motor nucleus of the rat spinal cord. Science 210, 564–566.
doi: 10.1126/science.7423210
Brockington, A., Ning, K., Heath, P. R., Wood, E., Kirby, J., Fusi, N., et al.
(2013). Unravelling the enigma of selective vulnerability in neurodegeneration:
motor neurons resistant to degeneration in ALS show distinct gene expression
characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol.
125, 95–109. doi: 10.1007/s00401-012-1058-5
Broens, P. M. A., Penninckx, F. M., and Ochoa, J. B. (2013). Fecal continence
revisited: the anal external sphincter continence reflex. Dis. Colon Rectum 56,
1273–1281. doi: 10.1097/dcr.0b013e3182a42d16
Callaghan, B., Furness, J. B., and Pustovit, R. V. (2018). Neural pathways
for colorectal control, relevance to spinal cord injury and treatment:
a narrative review. Spinal Cord 56, 199–205. doi: 10.1038/s41393-017
-0026-2
Cave, C., and Sockanathan, S. (2018). Transcription factor mechanisms guiding
motor neuron differentiation and diversification. Curr. Opin. Neurobiol. 53,
1–7. doi: 10.1016/j.conb.2018.04.012
Chéhensse, C., Bahrami, S., Denys, P., Clément, P., Bernabé, J., and Giuliano, F.
(2013). The spinal control of ejaculation revisited: a systematic review and
meta-analysis of anejaculation in spinal cord injured patients. Hum. Reprod.
Update 19, 507–526. doi: 10.1093/humupd/dmt029
Chia, R., Chiò, A., and Traynor, B. J. (2018). Novel genes associated with
amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet
Neurol. 17, 94–102. doi: 10.1016/s1474-4422(17)30401-5
Chun, A. L., Wallace, L. J., Gerald, M. C., Levin, R. M., and Wein, A. J. (1988).
Effect of age on in vivo urinary bladder function in the rat. J. Urol. 139, 625–627.
doi: 10.1016/s0022-5347(17)42546-8
de Groat, W. C. (2017). ‘‘Autonomic nervous system: central urogenital control,’’
in Reference Module in Neuroscience and Biobehavioral Psychology, (Elsevier),
983–992. Available online at: https://www.sciencedirect.com/science/article/
pii/B9780128093245018228?via%3Dihub.
de Groat, W. C., and Yoshimura, N. (2006). Mechanisms underlying the recovery
of lower urinary tract function following spinal cord injury. Prog. Brain Res.
152, 59–84. doi: 10.1016/S0079-6123(05)52005-3
Del Tredici, K., Ludolph, A. C., Feldengut, S., Jacob, C., Reichmann, H., Bohl, J. R.,
et al. (2020). Fabry disease with concomitant lewy body disease. J. Neuropathol.
Exp. Neurol. 79, 378–392. doi: 10.1093/jnen/nlz139
Del-Ser, T., Munoz, D. G., andHachinski, V. (1996). Temporal pattern of cognitive
decline and incontinence is different in Alzheimer’s disease and diffuse Lewy
body disease. Neurology 46, 682–686. doi: 10.1212/wnl.46.3.682
Dyro, F. M., and Bauer, S. B. (1990). Neurology of the neuromuscular disorders.
Ann. Neurol. Sci. 98S:333.
Eckert, M. J., and Martin, M. J. (2017). Trauma: spinal cord injury. Surg. Clin.
North Am. 97, 1031–1045. doi: 10.1016/j.suc.2017.06.008
Falzarano, M. S., Scotton, C., Passarelli, C., and Ferlini, A. (2015). Duchenne
muscular dystrophy: from diagnosis to therapy. Molecules 20, 18168–18684.
doi: 10.3390/molecules201018168
Forger, N. G., and Breedlove, S. M. (1986). Sexual dimorphism in human and
canine spinal cord: role of early androgen. Proc. Natl. Acad. Sci. U S A 83,
7527–7531. doi: 10.1073/pnas.83.19.7527
Forger, N. G., Roberts, S. L., Wong, V., and Breedlove, S. M. (1993). Ciliary
neurotrophic factor maintains motoneurons and their target muscles in
developing rats. J. Neurosci. 13, 4720–4726. doi: 10.1523/JNEUROSCI.13-11-
04720.1993
Fowler, C. J., Griffiths, D., and de Groat, W. C. (2008). The neural control of
micturition. Nat. Rev. Neurosci. 9, 453–466. doi: 10.1038/nrn2401
Frey, D., Schneider, C., Xu, L., Borg, J., Spooren, W., and Caroni, P. (2000).
Early and selective loss of neuromuscular synapse subtypes with low
sprouting competence in motoneuron diseases. J. Neurosci. 20, 2534–2542.
doi: 10.1523/JNEUROSCI.20-07-02534.2000
Gallo, F., Ninotta, G., Schenone, M., Cortese, P., and Giberti, C. (2019). Advances
in stem cell therapy for male stress urinary incontinence. Expert Opin. Biol.
Ther. 19, 293–300. doi: 10.1080/14712598.2019.1578343
Gang,W., Hongjian, T., Jasheng, C., Jiemin, S., Zhong, C., Yuemin, X., et al. (2014).
The effect of the 5-HT7 serotonin receptor agonist, LP44, on micturition
in rats with chronic spinal cord injury. Neurourol. Urodyn. 33, 1165–1170.
doi: 10.1002/nau.22463
Gerrits, P. O., Sie, J. A., and Holstege, G. (1997). Motoneuronal location
of the external urethral and anal sphincters: a single and double labeling
study in the male and female golden hamster. Neurosci. Lett. 226, 191–194.
doi: 10.1016/s0304-3940(97)00279-6
Gerstenberg, T. C., Levin, R. J., andWagner, G. (1990). Erection and ejaculation in
man. Assessment of the electromyographic activity of the bulbocavernosus and
ischiocavernosus muscles. Br. J. Urol. 65, 395–402. doi: 10.1111/j.1464-410x.
1990.tb14764.x
Gibson, S. J., Polak, J. M., Katagiri, T., Su, H., Weller, R. O., Brownell, D. B., et al.
(1988). A comparison of the distributions of eight peptides in spinal cord from
normal controls and cases of motor neurone disease with special reference to
Onuf’s nucleus. Brain Res. 474, 255–278. doi: 10.1016/0006-8993(88)90440-4
Guertin, P. A. (2016). New pharmacological approaches against chronic bowel
and bladder problems in paralytics. World J. Crit. Care Med. 5, 1–6.
doi: 10.5492/wjccm.v5.i1.1
Gunetti, M., Tomasi, S., Giammò, A., Boido, M., Rustichelli, D., Mareschi, K.,
et al. (2012). Myogenic potential of whole bone marrow mesenchymal stem
cells in vitro and in vivo for usage in urinary incontinence. PLoS One 7:e45538.
doi: 10.1371/journal.pone.0045538
Haidet-Phillips, A. M., Hester, M. E., Miranda, C. J., Meyer, K., Braun, L.,
Frakes, A., et al. (2011). Astrocytes from familial and sporadic ALS patients
are toxic to motor neurons. Nat. Biotechnol. 29, 824–828. doi: 10.1038/
nbt.1957
Hald, T., and Horn, T. (1998). The human urinary bladder in ageing. Br. J. Urol.
82, 59–64. doi: 10.1046/j.1464-410x.1998.0820s1059.x
Halliday, G. M., Macdonald, V., and Henderson, J. M. (2005). A comparison
of degeneration in motor thalamus and cortex between progressive
supranuclear palsy and Parkinson’s disease. Brain 128, 2272–2280.
doi: 10.1093/brain/awh596
Han, D. Y., Kobayashi, M., Nakano, M., Atobe, Y., Kadota, T., and Funakoshi, K.
(2009). Differential Islet-1 expression among lumbosacral spinal motor
neurons in prenatal mouse. Brain Res. 1265, 30–36. doi: 10.1016/j.brainres.
2009.02.020
Haylen, B. T., de Ridder, D., Freemanm, R. M., Swift, S. E., Berghmans, B.,
Lee, J., et al. (2010). An international urogynecological association
(IUGA)/international continence society (ICS) joint report on the
terminology for female pelvic floor dysfunction. Int. Urogynecol. J. 21,
5–26. doi: 10.1007/s00192-009-0976-9
Hedlund, E., Karlsson, M., Osborn, T., Ludwig, W., and Isacson, O. (2010). Global
gene expression profiling of somatic motor neuron populations with different
vulnerability identify molecules and pathways of degeneration and protection.
Brain 133, 2313–2330. doi: 10.1093/brain/awq167
Hochman, S., Fedirchuk, B., and Shefchyk, S. J. (1991). Membrane
electrical properties of external urethral and external anal sphincter
somatic motoneurons in the decerebrate cat. Neurosci. Lett. 127, 87–90.
doi: 10.1016/0304-3940(91)90901-5
Hodder, J. (1997). Shy drager syndrome. Axone 18, 75–79.
Holstege, G. (2005). Micturition and the soul. J. Comp. Neurol. 493, 15–20.
doi: 10.1002/cne.20785
Holstege, G. (2016). How the emotional motor system controls the pelvic organs.
Sex. Med. Rev. 4, 303–328. doi: 10.1016/j.sxmr.2016.04.002
Holstege, G., and Tan, J. (1987). Supraspinal control of motoneurons innervating
the striated muscles of the pelvic floor including urethral and anal sphincters in
the cat. Brain 110, 1323–1344. doi: 10.1093/brain/110.5.1323
Iwata, M., and Hirano, A. (1978). Sparing of the Onufrowicz nucleus in sacral
anterior horn lesions. Ann. Neurol. 4, 245–249. doi: 10.1002/ana.410040309
Iwata, M., Inoue, K., and Mannen, T. (1993). Functional localization in the
Onufrowicz nucleus in man. Clin. Neuropathol. 12, 112–116.
Iwatsubo, T., Kuzuhara, S., Kanemitsu, A., Shimada, H., and Toyokura, Y. (1990).
Corticofugal projections to the motor nuclei of the brainstem and spinal cord
in humans. Neurology 40, 309–312. doi: 10.1212/wnl.40.2.309
Jankowska, E., Padel, Y., and Zarzecki, P. (1978). Crossed disynaptic inhibition
of sacral motoneurones. J. Physiol. 285, 425–444. doi: 10.1113/jphysiol.1978.
sp012580
Jordan, C. L., Padgett, B., Hershey, J., Prins, G., and Arnold, A. (1997). Ontogeny
of androgen receptor immunoreactivity in lumbar motoneurons and in the
sexually dimorphic levator ani muscle of male rats. J. Comp. Neurol. 379, 88–98.
doi: 10.1002/(sici)1096-9861(19970303)379:1<88::aid-cne6>3.0.co;2-e
Frontiers in Neuroanatomy | www.frontiersin.org 11 September 2020 | Volume 14 | Article 572013
Schellino et al. Morpho-functional Features of Onuf’s Nucleus
Jost, W., and Marsalek, P. (2004). Duloxetine: mechanism of action at the
lower urinary tract and Onuf’s nucleus. Clin. Auton. Res. 14, 220–227.
doi: 10.1007/s10286-004-0197-8
Jung, J., Ahn, H. K., and Huh, Y. (2012). Clinical and functional anatomy of
the urethral sphincter. Int. Neurourol. J. 16, 102–106. doi: 10.5213/inj.2012.16.
3.102
Kaplan, A., Spiller, K. J., Towne, C., Kanning, K. C., Choe, G. T., Geber, A.,
et al. (2014). Neuronal matrix metalloproteinase-9 is a determinant of
selective neurodegeneration. Neuron 81, 333–348. doi: 10.1016/j.neuron.2013.
12.009
Kasashima, S., and Oda, Y. (2003). Cholinergic neuronal loss in the
basal forebrain and mesopontine tegmentum of progressive supranuclear
palsy and corticobasal degeneration. Acta Neuropathol. 105, 117–124.
doi: 10.1007/s00401-002-0621-x
Katagiri, T., Kuzirai, T., Nihei, K., Honda, K., Sasaki, H., and Polak, J. M. (1988).
Immunocytochemical study of Onuf’s nucleus in amyotrophic lateral sclerosis.
Jpn. J. Med. 27, 23–28. doi: 10.2169/internalmedicine1962.27.23
Kawatani, M., Nagel, J., and De Groat, W. C. (1986). Identification of
neuropeptides in pelvic and pudendal nerve afferent pathways to the sacral
spinal cord of the cat. J. Comp. Neurol. 249, 117–132. doi: 10.1002/cne.
902490109
Khanna, R., Soska, R., Lun, Y., Feng, J., Frascella, M., Young, B., et al. (2010).
The pharmacological chaperone 1-deoxygalactonojirimycin reduces tissue
globotriaosylceramide levels in a mouse model of Fabry disease.Mol. Ther. 18,
23–33. doi: 10.1038/mt.2009.220
Kihira, T., Yoshida, S., Yoshimasu, F., Wakayama, I., and Yase, Y. (1997).
Involvement of Onuf’s nucleus in amyotrophic lateral sclerosis. J. Neurol. Sci.
147, 81–88. doi: 10.1016/s0022-510x(96)05313-0
Kojima, M., Matsuura, T., Tanaka, A., Amagai, T., Imanishi, J., and Sano, Y.
(1985). Characteristic distribution of noradrenergic terminals on the
anterior horn motoneurons innervating the perineal striated muscles in the
rat. An immuno-electromicroscopic study. Anat. Embryol. 171, 267–273.
doi: 10.1007/bf00347015
Krassioukov, A., and Elliott, S. (2017). Neural control and physiology of sexual
function: effect of spinal cord injury. Top. Spinal Cord Inj. Rehabil. 23, 1–10.
doi: 10.1310/sci2301-1
Kuipers, R., Mouton, L. J., and Holstege, G. (2006). Afferent projections to
the pontine micturition center in the cat. J. Comp. Neurol. 494, 36–53.
doi: 10.1002/cne.20775
Kumagai, T., andHashizume, Y. (1982). Morphological andmorphometric studies
on the spinal cord lesion in Werdnig-Hoffmann disease. Brain Dev. 4, 87–96.
doi: 10.1016/s0387-7604(82)80002-8
Kuroiwa, T., Kuwata, T., Okeda, R., Asou, S., Nonaka, I., Ichinose, S., et al.
(1997). Case report a case of werdnig-hoffmann disease showing extensive
sensory involvement after prolonged mechanical ventilation. Neuropathology
17, 230–237. doi: 10.1111/j.1440-1789.1997.tb00044.x
Libelius, R., and Johansson, F. (2000). Quantitative electromyography of the
external anal sphincter in Parkinson’s disease and multiple system atrophy.
Muscle Nerve 23, 1250–1256. doi: 10.1002/1097-4598(200008)23:8<1250::aid-
mus14>3.0.co;2-w
Little, C. M., Coons, K. D., and Sengelaub, D. R. (2009). Neuroprotective effects
of testosterone on the morphology and function of somatic motoneurons
following the death of neighboring motoneurons. J. Comp. Neurol. 512,
359–372. doi: 10.1002/cne.21885
Lynch, A. C., and Frizelle, F. A. (2006). Colorectal motility and defecation
after spinal cord injury in humans. Prog. Brain Res. 152, 335–343.
doi: 10.1016/s0079-6123(05)52022-3
Malykhina, A. P. (2017). How the brain controls urination. eLife 6:e33219.
doi: 10.7554/elife.33219
Mannen, T. (1991). Neuropathology of Onuf’s nucleus. Rinsho Shinkeigaku 12,
1281–1285.
Mannen, T. (2000). Neuropathological findings of Onuf’s nucleus and its
significance. Neuropathology 20, S30–S33. doi: 10.1046/j.1440-1789.2000.
00298.x
Mannen, T., Iwata, M., Toyokura, Y., and Nagashima, K. (1982). The
Onuf’s nucleus and the external anal sphincter muscles in amyotrophic
lateral sclerosis and Shy-Drager syndrome. Acta Neuropathol. 58, 255–260.
doi: 10.1007/bf00688606
Merry, D. (2001). ‘‘Pathophysiology of spinal and bulbar muscular atrophy,’’
in Molecular Mechanisms of Neurodegenerative Diseases, ed. M. F. Chesselet
(Totowa, New Jersey: Humana Press), 307–326. Available online at: https://
www.springer.com/gp/book/9780896038042.
Michel, M. C., and Peters, S. L. (2004). Role of serotonin and noradrenaline in
stress urinary incontinence. BJU Int. 94, 23–30. doi: 10.1111/j.1464-410x.2004.
04811.x
Michels, L., Blok, B. F., Gregorini, F., Kurz, M., Schurch, B., Kessler, T. M.,
et al. (2015). Supraspinal control of urine storage and micturition in
men—an fMRI study. Cereb. Cortex 25, 3369–3380. doi: 10.1093/cercor/
bhu140
Morisaki, Y., Niikura, M., Watanabe, M., Onishi, K., Tanabe, S., Moriwaki, Y.,
et al. (2016). Selective expression of osteopontin in als-resistant motor neurons
is a critical determinant of late phase neurodegeneration mediated by matrix
metalloproteinase-9. Sci. Rep. 6:27354. doi: 10.1038/srep27354
Nakagawa, S. (1980). Onuf’s nucleus of the sacral cord in a South American
monkey (Saimiri): its location and bilateral cortical input from area 4. Brain
Res. 191, 337–344. doi: 10.1016/0006-8993(80)91285-8
Ni, J., Cao, N., Wang, X., Zhan, C., Si, J., Gu, B., et al. (2019). The serotonin (5-
hydroxytryptamine) 5-HT7 receptor is up-regulated in Onuf’s nucleus in rats
with chronic spinal cord injury. BJU Int. 123, 718–725. doi: 10.1111/bju.14405
Nijssen, J., Comley, L. H., and Hedlund, E. (2017). Motor neuron vulnerability
and resistance in amyotrophic lateral sclerosis.Acta Neuropathol. 133, 863–885.
doi: 10.1007/s00401-017-1708-8
Norman, R. M., and Kay, J. M. (1965). Cerebello-thalamo-spinal degeneration in
infancy: an unusual variant of Werdnig-Hoffmann’s disease. Arch. Dis. Child.
40, 302–308. doi: 10.1136/adc.40.211.302
Okamoto, K., Hirai, S., Ishiguro, K., Kawarabayashi, T., and Takatama, M. (1991).
Light and electron microscopic and immunohistochemical observations of the
Onuf’s nucleus of amyotrophic lateral sclerosis.Acta Neuropathol. 81, 610–614.
doi: 10.1007/bf00296370
Onuf, B. (1899). Notes on the arrangement and function of the cell groups
in the sacral region of the spinal cord. J. Nerv. Ment Disord. 26, 498–504.
doi: 10.1097/00005053-189908000-00006
Onuf, B. (1900). Notes on the arrangement and function of the cell groups in the
sacral region of the spinal cord in man. Arch. Neurol. Psychopathol. 3, 387–411.
O’Sullivan, S. S., Holton, J. L., Massey, L. A., Williams, D. R., Revesz, T.,
and Lees, A. J. (2008). Parkinson’s disease with Onuf’s nucleus involvement
mimicking multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 79,
232–234. doi: 10.1136/jnnp.2007.133314
Padmanabhan, P., and Dmochowski, R. (2014). Urinary incontinence in women:
a comprehensive review of the pathophysiology, diagnosis and treatment.
Minerva Ginecol. 66, 469–478.
Panicker, J. N. (2019). The Onuf’s nucleus, serotonin and spinal cord injury. BJU
Int. 123, 716–717. doi: 10.1111/bju.14634
Piccione, E. A., Sletten, D. M., Staff, N. P., and Low, P. A. (2015). Autonomic
system and amyotrophic lateral sclerosis. Muscle Nerve 51, 676–679.
doi: 10.1002/mus.24457
Pullen, A. H., and Martin, J. E. (1995). Ultrastructural abnormalities with
inclusions in Onuf’s nucleus in motor neuron disease (amyotrophic lateral
sclerosis).Neuropathol. Appl. Neurobiol. 21, 327–340. doi: 10.1111/j.1365-2990.
1995.tb01067.x
Pullen, A. H., Tucker, D., and Martin, J. E. (1997). Morphological and
morphometric characterisation of Onuf’s nucleus in the spinal cord in man.
J. Anat. 191, 201–213. doi: 10.1046/j.1469-7580.1997.19120201.x
Ramírez-León, V., Hökfelt, T., Cuello, A. C., Visser, T. J., and Ulfhake, B.
(1994). Enkephalin-, thyrotropin-releasing hormone- and substance
P-immunoreactive axonal innervation of the ventrolateral dendritic bundle
in the cat sacral spinal cord: an ultrastructural study. J. Chem. Neuroanat. 7,
203–215. doi: 10.1016/0891-0618(94)90013-2
Ransmayr, G. N., Holliger, S., Schletterer, K., Heidler, H., Deibl, M., Poewe, W.,
et al. (2008). Lower urinary tract symptoms in dementia with Lewy
bodies, Parkinson disease, and Alzheimer disease. Neurology 70, 299–303.
doi: 10.1212/01.wnl.0000296826.61499.26
Ranson, R. N., Dodds, A. L., Smith, M. J., Santer, R. M., and Watson, A. H.
(2003). Age-associated changes in the monoaminergic innervation of rat
lumbosacral spinal cord. Brain Res. 972, 149–158. doi: 10.1016/s0006-8993(03)
02521-6
Frontiers in Neuroanatomy | www.frontiersin.org 12 September 2020 | Volume 14 | Article 572013
Schellino et al. Morpho-functional Features of Onuf’s Nucleus
Ravnik, D., and Sirca, A. (1993). Histochemical characteristics of bulbospongiosus
and ischiocavernosus muscles in man. Ann. Anat. 175, 135–135.
doi: 10.1016/s0940-9602(11)80168-8
Robberecht, W., and Philips, T. (2013). The changing scene of amyotrophic lateral
sclerosis. Nat. Rev. Neurosci. 14, 248–264. doi: 10.1038/nrn3430
Rochat, C., Bernard-Marissal, N., and Schneider, B. L. (2016). ‘‘Selective
vulnerability of neuronal subtypes in ALS: a fertile ground for the identification
of therapeutic targets,’’ in Update on Amyotrophic Lateral Sclerosis, eds
H. F. Sibat and L. Ibañez-Valdés (London: InTech), 165–194. Available online
at: https://www.intechopen.com/page/contact-us.
Sakakibara, R., Tateno, F., Kishi, M., Tsuyuzaki, Y., Uchiyama, T., and
Yamamoto, T. (2012). Pathophysiology of bladder dysfunction in Parkinson’s
disease. Neurobiol. Dis 46, 565–571. doi: 10.1016/j.nbd.2011.10.002
Sakamoto, H. (2014). Sexually dimorphic nuclei in the spinal cord control male
sexual functions. Front. Neurosci. 8:184. doi: 10.3389/fnins.2014.00184
Sar, M., and Stumpf, W. E. (1977). Androgen concentration in motor neurons of
cranial nerves and spinal cord. Science 197, 77–79. doi: 10.1126/science.867053
Sasaki, M. (1991). Membrane properties of external urethral and external
anal sphincter motoneuronesin the cat. J. Physiol. 440, 345–366.
doi: 10.1113/jphysiol.1991.sp018712
Sasaki, M. (1994). Morphological analysis of external urethral and external anal
sphinctermotoneuronesof cat. J. Comp. Neurol. 349, 269–287. doi: 10.1002/cne.
903490209
Scaravilli, T., Pramstaller, P. P., Salerno, A., Egarter-Vigl, E., Giometto, B.,
Vitaliani, R., et al. (2000). Neuronal loss in Onuf’s nucleus in three patients with
progressive supranuclear palsy. Ann. Neurol. 48, 97–101. doi: 10.1002/1531-
8249(200007)48:1<97::aid-ana14>3.0.co;2-z
Schrøder, H. D. (1981). Onuf’s nucleus X: amorphological study of a human spinal
nucleus. Anat. Embryol. 162, 443–453. doi: 10.1007/bf00301870
Schrøder, H. D., and Reske-Nielsen, E. (1983). Fiber types in the striated urethral
and anal sphincters. Acta Neuropathol. 60, 278–282. doi: 10.1007/bf00691877
Shaw, P. J., and Eggett, C. J. (2000). Molecular factors underlying selective
vulnerability of motor neurons to neurodegeneration in amyotrophic lateral
sclerosis. J. Neurol. 247, I17–I27. doi: 10.1007/BF03161151
Shvil, N., Banerjee, V., Zoltsman, G., Shani, T., Kahn, J., Abu-Hamad, S.,
et al. (2018). MIF inhibits the formation and toxicity of misfolded
SOD1 amyloid aggregates: implications for familial ALS. Cell Death Dis. 9:107.
doi: 10.1038/s41419-017-0130-4
Shy, G. M., and Drager, G. A. (1960). A neurological syndrome associated with
orthostatic hypotension. A clinical-pathologic study. Arch. Neurol. 2, 511–527.
doi: 10.1001/archneur.1960.03840110025004
Sobue, G., Matsuoka, Y., Mukai, E., Takayanagi, T., Sobue, I., and Hashizume, Y.
(1981). Spinal and cranial motor nerve roots in amyotrophic lateral sclerosis
and X-linked recessive bulbospinal muscular atrophy: morphometric and
teased-fiber study. Acta Neuropathol. 55, 227–227. doi: 10.1007/bf00691322
Sumner, C. J., Paushkin, S., and Ko, C. P. (2017). Spinal Muscular Atrophy: Disease
Mechanisms and Therapy. Amsterdam, The Netherlands: Elsevier/Academic
Press.
Sung, J. H. (1979). Autonomic neurons affected by lipid storage in the spinal
cord in Fabry’s disease: distribution of autonomic neurons in the sacral cord.
J. Neuropathol. Exp. Neurol. 38, 87–98. doi: 10.1097/00005072-197903000-
00001
Sung, J. H., Mastri, A. E., and Segal, E. (1979). Pathology of Shy-Drager syndrome.
J. Neuropathol. Exp. Neurol. 38, 353–368. doi: 10.1097/00005072-197907000-
00001
Takeda, T., Uchihara, T., Nakayama, Y., Nakamura, A., Sasaki, S., Kakei, S.,
et al. (2014). Dendritic retraction, but not atrophy, is consistent in
amyotrophic lateral sclerosis-comparison between Onuf’s neurons and other
sacral motor neurons. Acta Neuropathol. Commun. 2:11. doi: 10.1186/2051-59
60-2-11
Tashiro, T., Satoda, T., Matsushima, R., and Mizuno, N. (1989a). Convergence of
serotonin-, enkephalin- and substance P-like immunoreactive afferent fibers on
single pudendal motoneurons in Onuf’s nucleus of the cat: a light microscope
study combining the triple immunocytochemical staining technique with the
retrograde HRP-tracing method. Brain Res. 481, 392–398. doi: 10.1016/0006-
8993(89)90821-4
Tashiro, T., Satoda, T., Matsushima, R., and Mizuno, N. (1989b). Possible
origins of substance P-like immunoreactive axons within Onuf’s
nucleus of the cat. Brain Res. 497, 177–182. doi: 10.1016/0006-8993(89)
90985-2
Thor, K. B. (2004). Targeting serotonin and norepinephrine receptors in stress
urinary incontinence. Int. J. Gynaecol. Obstet. 86, S38–S52. doi: 10.1016/j.ijgo.
2004.04.028
Vercelli, A., and Cracco, C. (1989). Influence of testosterone on the development
of the ischiocavernosus muscle of the rat. Acta Anat. 134, 177–183.
doi: 10.1159/000146684
Vercelli, A., and Cracco, C. (1990). Effects of prepubertal castration on the spinal
motor nucleus of the ischiocavernosus muscle of the rat. Cell. Tissue Res. 262,
551–557. doi: 10.1007/bf00305252
Weld, K. J., Graney, M. J., and Dmochowski, R. R. (2000). Clinical significance
of detrusor sphincter dyssynergia type in patients with post-traumatic
spinal cord injury. Urology 56, 565–568. doi: 10.1016/s0090-4295(00)
00761-5
Winge, K., and Fowler, C. J. (2006). Bladder dysfunction in Parkinsonism:
mechanisms, prevalence, symptoms, and management. Mov. Disord. 21,
737–745. doi: 10.1002/mds.20867
Xu, C., Giuliano, F., Sun, X. Q., Brisorgueil, M. J., Leclerc, P., Vergé, D., et al.
(2007). Serotonin 5-HT2A and 5-HT5A receptors are expressed by different
motoneuron populations in rat Onuf’s nucleus. J. Comp. Neurol. 502, 620–634.
doi: 10.1002/cne.21344
Yamamoto, T., Sakakibara, R., Uchiyama, T., Liu, Z., Ito, T., Awa, Y., et al. (2005).
When is Onuf’s nucleus involved in multiple system atrophy? A sphincter
electromyography study. J. Neurol. Neurosurg. Psychiatry 76, 1645–1648.
doi: 10.1136/jnnp.2004.061036
Yamamoto, T., Sakakibara, R., Uchiyama, T., Yamaguchi, C., Ohno, S.,
Nomura, F., et al. (2014). Time-dependent changes and gender differences
in urinary dysfunction in patients with multiple system atrophy. Neurourol.
Urodyn. 33, 516–523. doi: 10.1002/nau.22441
Yamamoto, T., Tateno, F., Sakakibara, R., Furukawa, S., Asahina, M.,
Uchiyama, T., et al. (2016). Urinary dysfunction in progressive supranuclear
palsy compared with other parkinsonian disorders. PLoS One 11:e0149278.
doi: 10.1371/journal.pone.0149278
Yokoyama, O., Komatsu, K., Ishiura, Y., Akino, H., Kodama, K., Yotsuyanagi, S.,
et al. (2002). Overactive bladder—experimental aspects. Scand. J. Urol. Nephrol.
Suppl. 210, 59–64. doi: 10.1080/003655902320765980
Zhao, W., Aboushwareb, T., Turner, C., Mathis, C., Bennett, C., Sonntag, W. E.,
et al. (2010). Impaired bladder function in aging male rats. J. Urol. 184,
378–385. doi: 10.1016/j.juro.2010.03.004
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Schellino, Boido and Vercelli. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with
these terms.
Frontiers in Neuroanatomy | www.frontiersin.org 13 September 2020 | Volume 14 | Article 572013
